BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22487523)

  • 1. Invasive markers identified by gene expression profiling in pancreatic cancer.
    Rogers A; Smith MJ; Doolan P; Clarke C; Clynes M; Murphy JF; McDermott A; Swan N; Crotty P; Ridgway PF; Conlon KC
    Pancreatology; 2012; 12(2):130-40. PubMed ID: 22487523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer.
    Zhao YP; Chen G; Feng B; Zhang TP; Ma EL; Wu YD
    Chin Med J (Engl); 2007 Oct; 120(20):1743-52. PubMed ID: 18028764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.
    Nielsen A; Scarlett CJ; Samra JS; Gill A; Li Y; Allen BJ; Smith RC
    J Gastroenterol Hepatol; 2005 Feb; 20(2):256-63. PubMed ID: 15683429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
    Tan X; Egami H; Nozawa F; Abe M; Baba H
    Int J Oncol; 2006 Feb; 28(2):369-74. PubMed ID: 16391791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling.
    Hirono S; Yamaue H; Hoshikawa Y; Ina S; Tani M; Kawai M; Ushijima M; Matsuura M; Saiki Y; Saiura A; Yamamoto J; Miki Y; Noda T
    Cancer Sci; 2010 Jan; 101(1):259-66. PubMed ID: 19817750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
    Luparello C; Sirchia R; Pupello D
    J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
    He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
    Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.
    Tan X; Egami H; Ishikawa S; Sugita H; Kamohara H; Nakagawa M; Nozawa F; Abe M; Ogawa M
    Int J Oncol; 2005 May; 26(5):1283-9. PubMed ID: 15809719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confirmation of DNA microarray-derived differentially expressed genes in pancreatic cancer using quantitative RT-PCR.
    Streit S; Michalski CW; Erkan M; Friess H; Kleeff J
    Pancreatology; 2009; 9(5):577-82. PubMed ID: 19657213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
    Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
    Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer.
    Friess H; Ding J; Kleeff J; Fenkell L; Rosinski JA; Guweidhi A; Reidhaar-Olson JF; Korc M; Hammer J; Büchler MW
    Cell Mol Life Sci; 2003 Jun; 60(6):1180-99. PubMed ID: 12861384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tumor microenvironment on gene expression in pancreatic cancer tumor models.
    Mees ST; Mardin WA; Schleicher C; Colombo-Benkmann M; Senninger N; Haier J
    J Surg Res; 2011 Nov; 171(1):136-42. PubMed ID: 20605603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
    Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE
    Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.